Pharmacological aspects of ANGPTL3 and ANGPTL4 inhibitors: New therapeutic approaches for the treatment of atherogenic dyslipidemia

M Ruscica, F Zimetti, MP Adorni, CR Sirtori… - Pharmacological …, 2020 - Elsevier
Among the determinants of atherosclerotic cardiovascular disease (ASCVD), genetic and
experimental evidence has provided data on a major role of angiopoietin-like proteins 3 and …

Lipoprotein lipase: Biosynthesis, regulatory factors, and its role in atherosclerosis and other diseases

PP He, T Jiang, XP OuYang, YQ Liang, JQ Zou… - Clinica chimica acta, 2018 - Elsevier
Lipoprotein lipase (LPL) is a rate-limiting enzyme that catalyzes hydrolysis of the triglyceride
(TG) core of circulating TG-rich lipoproteins including chylomicrons (CM), low-density …

LILRB2/PirB mediates macrophage recruitment in fibrogenesis of nonalcoholic steatohepatitis

DP Li, L Huang, RR Kan, XY Meng, SY Wang… - Nature …, 2023 - nature.com
Inhibition of immunocyte infiltration and activation has been suggested to effectively
ameliorate nonalcoholic steatohepatitis (NASH). Paired immunoglobulin-like receptor B …

Angiopoietin-like protein 8 differentially regulates ANGPTL3 and ANGPTL4 during postprandial partitioning of fatty acids [S]

YQ Chen, TG Pottanat, RW Siegel, M Ehsani… - Journal of Lipid …, 2020 - ASBMB
Angiopoietin-like protein (ANGPTL) 8 has been implicated in metabolic syndrome and
reported to regulate adipose FA uptake through unknown mechanisms. Here, we studied …

ANGPTL8 requires ANGPTL3 to inhibit lipoprotein lipase and plasma triglyceride clearance [S]

JF Haller, IJ Mintah, LM Shihanian, P Stevis… - Journal of lipid …, 2017 - ASBMB
Abstract Angiopoietin-like (ANGPTL) 3 and ANGPTL8 are secreted proteins and inhibitors of
LPL-mediated plasma triglyceride (TG) clearance. It is unclear how these two ANGPTL …

On the mechanism of angiopoietin-like protein 8 for control of lipoprotein lipase activity

O Kovrov, KK Kristensen, E Larsson, M Ploug… - Journal of lipid …, 2019 - ASBMB
Angiopoietin-like (ANGPTL) 8 is a secreted inhibitor of LPL, a key enzyme in plasma
triglyceride metabolism. It was previously reported that ANGPTL8 requires another member …

An anti-ANGPTL3/8 antibody decreases circulating triglycerides by binding to a LPL-inhibitory leucine zipper-like motif

D Balasubramaniam, O Schroeder, AM Russell… - Journal of Lipid …, 2022 - ASBMB
Triglycerides (TG) are required for fatty acid transport and storage and are essential for
human health. Angiopoietin-like-protein 8 (ANGPTL8) has previously been shown to form a …

ANGPTL8 negatively regulates NF-κB activation by facilitating selective autophagic degradation of IKKγ

Y Zhang, X Guo, W Yan, Y Chen, M Ke… - Nature …, 2017 - nature.com
Excessive nuclear factor-κB (NF-κB) activation mediated by tumor necrosis factor α (TNFα)
plays a critical role in inflammation. Here we demonstrate that angiopoietin-like 8 …

Angiopoietin-like proteins as therapeutic targets for cardiovascular disease: focus on lipid disorders

MB Morelli, C Chavez, G Santulli - Expert opinion on therapeutic …, 2020 - Taylor & Francis
ABSTRACT Introduction: Angiopoietin-like (ANGPTL) proteins belong to a family of eight
secreted factors that are structurally related to proteins that modulate angiogenesi …

Triglyceride metabolism and angiopoietin-like proteins in lipoprotein lipase regulation

J Li, L Li, DM Guo, SY Li, YX Zeng, CH Liu, RU Fu… - Clinica Chimica …, 2020 - Elsevier
Hypertriglyceridemia is a risk factor for a series of diseases, such as cardiovascular disease
(CVD), diabetes and nonalcoholic fatty liver disease (NAFLD). Angiopoietin-like proteins …